AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 2006519
Drug: Ciprofloxacin, 750
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ciprofloxacin, 750 mg p.o. b.i.d.
Trial: 7152771
Drug: Caffeine (6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caffeine (6 mg/kg body weight)
Trial: 18095196
Drug: Magnesium sulphate
RxNorm normalized name: Magnesium sulphate
DrugBank: Magnesium (DB14513)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Magnesium sulphate infusion (5 mg/kg bolus and 500 mg/h for 24 hours)
Trial: 10655909
Drug: Nafamostat mesilate
RxNorm normalized name: mesylate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nafamostat mesilate (kallikrein inhibitor)
Trial: 10655909
Drug: Lipid solvent
RxNorm normalized name: solvent yellow 18
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lipid solvent (injected twice)
Trial: 1874199
Drug: Midazolam 0.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midazolam 0.3 mg kg‐1 (Group 1)
Trial: 1874199
Drug: Midazolam 0.6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midazolam 0.6 mg kg‐1 (Group 2)
Trial: 2319047
Drug: 0.6 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.6 mg/kg methylphenidate
Trial: 6191948
Drug: Placebo (0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (0 mg/kg methylphenidate)
Trial: 22806681
Drug: telaprevir treatment
RxNorm normalized name: Telaprevir
DrugBank: Telaprevir (DB05521)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: telaprevir treatment
Trial: 17323793
Drug: Deximune soft‐gelatin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Deximune soft‐gelatin capsules (200 mg CsA)
Trial: 17323793
Drug: Sandimmune Neoral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sandimmune Neoral (200 mg CsA)
Trial: 17323793
Drug: Both formulations
RxNorm normalized name: Bothrops atrox venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both formulations (Deximune and Sandimmune)
Trial: 11597376
Drug: Topical GM-CSF
RxNorm normalized name: axatilimab-csfr
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical GM-CSF mouthwashes
Trial: 11597376
Drug: Combined topical
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined topical use of antiseptic agent (povidone-iodine) and amphotericin B (AA)
Trial: 1743806
Drug: 30 mg
RxNorm normalized name: agar 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg Parlodel-SRO administered in two intakes (b.i.d.)
Trial: 1743806
Drug: 30 mg
RxNorm normalized name: agar 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg Parlodel-SRO administered in one dose (once daily)
Trial: 1743806
Drug: 30 mg
RxNorm normalized name: agar 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg Parlodel-SRO administered in three intakes (t.i.d.)
Trial: 31027422
Drug: Memantine extended
RxNorm normalized name: memantine extended release oral kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Memantine extended release treatment in MEM‐MD‐91 trial
Trial: 31027422
Drug: Memantine extended
RxNorm normalized name: memantine extended release oral kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Memantine extended release treatment in MEM‐MD‐68 trial
Trial: 31027422
Drug: Memantine extended
RxNorm normalized name: memantine extended release oral kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Memantine extended release treatment in MEM‐MD‐69 trial
Trial: 27618090
Drug: 50 g-oats
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 g-oats group (n = 80)
Trial: 27618090
Drug: 100 g-oats
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 g-oats group (n = 79)
Trial: 23328283
Drug: Lactulose plus
RxNorm normalized name: Lactulose
DrugBank: Lactulose (DB00581)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Lactulose plus live combined Bacillus subtilis and Enterococcus faecium capsules for 14 days, followed by only Bacillus subtilis and Enterococcus faecium capsules for 14 days
Trial: 18060813
Drug: Pregabalin therapy
RxNorm normalized name: Pregabalin
DrugBank: Pregabalin (DB00230)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Pregabalin therapy
Trial: 25172950
Drug: Nifedipine (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nifedipine (20 nmol l(‐1))
Trial: 21358707
Drug: Citalopram (selective
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Citalopram (selective serotonin-uptake inhibitor) administered for 7 days
Trial: 10319076
Drug: Aggressive diet
RxNorm normalized name: phentermine hydrochloride Oral Capsule [T-Diet]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aggressive diet and exercise recommendations, lipid-lowering drugs according to NCEP guidelines
Trial: 8732324
Drug: Active treatment
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active treatment (nitrendipine combined with enalapril and/or hydrochlorothiazide)
Trial: 8517385
Drug: Simvastatin 10
RxNorm normalized name: simvastatin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simvastatin 10 mg, titrated to a maximum of 40 mg/day
Trial: 8517385
Drug: Pravastatin 10
RxNorm normalized name: pravastatin 10 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pravastatin 10 mg, titrated to a maximum of 40 mg/day
Trial: 3127574
Drug: Natural surfactant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Natural surfactant preparation consisting of lipids extracted from calf lung lavage
Trial: 26860807
Drug: Chinese herbal
RxNorm normalized name: GINGER 28 mg in 100 mL TOPICAL OIL [Pain Relief Honzo Seika Chinese Herbal Aroma Oil]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chinese herbal medicine (CHM) as maintenance therapy
Trial: 25130788
Drug: Endothelial cell-selective
RxNorm normalized name: endothelial growth factor A, vascular
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Endothelial cell-selective adhesion molecule levels in AKI group
Trial: 16428753
Drug: ACAM2010 vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ACAM2010 vaccine (5 x 10^9 CFU)
Trial: 11582899
Drug: Interpretive therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interpretive therapy
Trial: 10446037
Drug: 400 mg/day
RxNorm normalized name: ribociclib succinate 400 mg/day (200 mg x 2) ORAL TABLET
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 mg/day of alpha-tocopherol (n = 27)
Trial: 8005274
Drug: Episodic progesterone
RxNorm normalized name: Progesterone
DrugBank: Progesterone (DB00396)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Episodic progesterone (P) administration (12.5 mg IM on days 2 and 7) during the artificial follicular phase (Group A)
Trial: 8005274
Drug: Episodic progesterone
RxNorm normalized name: Progesterone
DrugBank: Progesterone (DB00396)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Episodic progesterone (P) administration (6.25 mg on days 3, 4, and 5) during the artificial follicular phase (Group B)
Trial: 4568265
Drug: Steroids for
RxNorm normalized name: CORTICOSTEROIDS FOR SYSTEMIC USE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Steroids for 7 to 8 days
Trial: 24382580
Drug: Robotic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Robotic therapy (ARMin exoskeleton robot)
Trial: 23477205
Drug: Dairy products
RxNorm normalized name: Food - Dairy Products, Whey, Cow's Milk
DrugBank: Whey (DB18685)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dairy products (932 mg Ca; n = 19)
Trial: 23477205
Drug: Calcium citrate
RxNorm normalized name: Calcium Citrate
DrugBank: Calcium sulfate (DB15533)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Calcium citrate tablets (1000 mg calcium/day; n = 18)
Trial: 18070045
Drug: Oxycodone controlled
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxycodone controlled release (Oxy-CR), 5-10 mg, q12 h/day
Trial: 14657879
Drug: Fish oil
RxNorm normalized name: Fish oil
DrugBank: Fish oil (DB13961)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fish oil (3.7 g n‐3 PUFAs per day)
Trial: 350263
Drug: Topical atenolol
RxNorm normalized name: Atenolol
DrugBank: Atenolol (DB00335)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Topical atenolol (2% 3 times a day)
Trial: 350263
Drug: Topical pilocarpine
RxNorm normalized name: Pilocarpine
DrugBank: Pilocarpine (DB01085)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Topical pilocarpine (2% 3 times a day)
Trial: 350263
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of 2% pilocarpine and 2% atenolol administered 15 minutes apart (3 times a day)
Trial: 26512597
Drug: PET-CT scan
RxNorm normalized name: Pet-ema
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PET-CT scan at 9 months (PET-CT9) after the start of radiation treatment
Trial: 19242343
Drug: Epoetin alfa
RxNorm normalized name: epoetin alfa
DrugBank: Erythropoietin (DB00016)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Epoetin alfa 40,000 IU once weekly, subcutaneously (group A)
Trial: 19242343
Drug: Epoetin alfa
RxNorm normalized name: epoetin alfa
DrugBank: Erythropoietin (DB00016)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Epoetin alfa 40,000 IU once weekly, intravenously (group B)
Trial: 19242343
Drug: All dosing
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All dosing regimens of epoetin alfa
Trial: 15679127
Drug: 3.0 mg
RxNorm normalized name: TOBRAMYCIN 3.0 mg in 1 mL OPHTHALMIC SOLUTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3.0 mg of tetracaine
Trial: 15679127
Drug: 6.0 mg
RxNorm normalized name: Dimethicone 6.0 mg in 30 mL TOPICAL CREAM [Clapiel Revital Serum]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6.0 mg of tetracaine
Trial: 9615801
Drug: MTH‐68/B vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MTH‐68/B vaccine treatment
Trial: 8087786
Drug: Conformal three-dimensional
RxNorm normalized name: three-lobe sage extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conformal three-dimensional (3D) radiation treatment
Trial: 8087786
Drug: Conventional radiation
RxNorm normalized name: allantoin
DrugBank: Allantoin (DB11100)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Conventional radiation treatment
Trial: 2575369
Drug: Cicletanine 100
RxNorm normalized name: cicletanine 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cicletanine 100 mg/day
Trial: 2514676
Drug: Cicletanine 200
RxNorm normalized name: cicletanine
DrugBank: Cicletanine (DB12766)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cicletanine 200 mg/day
Trial: 26510526
Drug: Astym therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Astym therapy
Trial: 26510526
Drug: Placebo (sham
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (sham Astym treatment)
Trial: 10102601
Drug: 5% lidocaine
RxNorm normalized name: LIDOCAINE 5 g in 100 g TOPICAL CREAM [Healcome Tattoo Numbing Cream 5% Lidocaine]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5% lidocaine ointment
Trial: 7788259
Drug: Intravesical methylene
RxNorm normalized name: Methylene Blue
DrugBank: Methylene blue (DB09241)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravesical methylene blue staining (1% solution)
Trial: 7198462
Drug: Plafibride at
RxNorm normalized name: rose bengal AT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Plafibride at 800 mg/d
Trial: 7198462
Drug: Plafibride at
RxNorm normalized name: rose bengal AT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Plafibride at 1600 mg/d
Trial: 25867447
Drug: Active treatment
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active treatment (nicotine patch, nicotine lozenge, bupropion SR, patch and lozenge, or bupropion SR and lozenge)
Trial: 25867447
Drug: Patch and
RxNorm normalized name: allogeneic cultured keratinocytes and dermal fibroblasts in murine collagen Medicated Patch [Stratagraft]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patch and lozenge combination
Trial: 24028629
Drug: Saccharomyces boulardii
RxNorm normalized name: Saccharomyces boulardii
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saccharomyces boulardii supplementation (250 mg/day)
Trial: 21301952
Drug: Protocol for
RxNorm normalized name: Olay Professional Acne Protocol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Protocol for an Office‐based Nurse‐administered Intervention (PONI) administered on-site by trained nurses over the course of 3-6 months.
Trial: 19237249
Drug: Opioid therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Opioid therapy (group 3)
Trial: 19237249
Drug: No opioid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No opioid therapy (group 2)
Trial: 19237249
Drug: No pain
RxNorm normalized name: Biochemistry Heel No Pain
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No pain or opioid therapy (group 1)
Trial: 17249848
Drug: Garenoxacin 600
RxNorm normalized name: Garénoxacine
DrugBank: Garenoxacin (DB06160)
FDA approved: no
EMA approved: no
PMDA approved: yes
Description: Garenoxacin 600 mg as intact tablets
Trial: 17249848
Drug: Garenoxacin 600
RxNorm normalized name: Garénoxacine
DrugBank: Garenoxacin (DB06160)
FDA approved: no
EMA approved: no
PMDA approved: yes
Description: Garenoxacin 600 mg as crushed tablets via NG tube
Trial: 17249848
Drug: Garenoxacin 600
RxNorm normalized name: Garénoxacine
DrugBank: Garenoxacin (DB06160)
FDA approved: no
EMA approved: no
PMDA approved: yes
Description: Garenoxacin 600 mg as crushed tablets via NG tube with concomitant enteral feeding (Osmolite; 600 mL at 100 mL/h)
Trial: 15236891
Drug: 24 h
RxNorm normalized name: Immune 24 Hour +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 24 h intravenous hydration
Trial: 15236891
Drug: No intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No intravenous hydration (Control)
Trial: 11597795
Drug: Cumulative duration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cumulative duration of combined therapy
Trial: 9145729
Drug: Amoxicillin/clavulanate (875/125
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxicillin/clavulanate (875/125 mg) every 12 hours
Trial: 9145729
Drug: Amoxicillin/clavulanate (500/125
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxicillin/clavulanate (500/125 mg) every 8 hours
Trial: 11557915
Drug: Isosorbide dinitrate
RxNorm normalized name: Isosorbide Dinitrate
DrugBank: Isosorbide dinitrate (DB00883)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Isosorbide dinitrate 5 mg
Trial: 3034316
Drug: enalapril maleate
RxNorm normalized name: Enalapril Maleate
DrugBank: Enalapril (DB00584)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: enalapril maleate 10 mg orally
Trial: 3034316
Drug: enalapril maleate
RxNorm normalized name: Enalapril Maleate
DrugBank: Enalapril (DB00584)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: enalapril maleate 5 mg intravenously
Trial: 3032562
Drug: enalaprilat 5
RxNorm normalized name: Enalaprilat
DrugBank: Enalaprilat (DB09477)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: enalaprilat 5 mg intravenously
Trial: 3034316
Drug: oral administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: oral administration of 10 mg enalapril maleate
Trial: 26486702
Drug: Intradermal (ID)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intradermal (ID) influenza vaccine (15 µg)
Trial: 26486702
Drug: Intramuscular (IM)
RxNorm normalized name: intramuscular immunoglobulin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular (IM) influenza vaccine (15 µg)
Trial: 25418440
Drug: Delayed primary
RxNorm normalized name: Sodium primary phosphate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Delayed primary excision (DPE) with adjusted radiation therapy (RT) dose
Trial: 25418440
Drug: Radiation therapy
RxNorm normalized name: Sensitizers used in photodynamic/radiation therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Radiation therapy (RT) dose of 36 Gy, 41.4 Gy, or 50.4 Gy based on DPE results
Trial: 25418440
Drug: IRS-IV standard
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IRS-IV standard treatment without DPE
Trial: 15684258
Drug: Lidocaine 0.5
RxNorm normalized name: LIDOCAINE 0.5% GEL,TOP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lidocaine 0.5 mg.kg(‐1)
Trial: 15684258
Drug: Lidocaine 1.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lidocaine 1.0 mg.kg(‐1)
Trial: 15684258
Drug: Lidocaine 1.5
RxNorm normalized name: LIDOCAINE 1.5%/EPI 1:200000 INJ
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lidocaine 1.5 mg.kg(‐1)
Trial: 11850268
Drug: Liposomal amphotericin
RxNorm normalized name: Liposomal amphotericin B
DrugBank: Amphotericin B (DB00681)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Liposomal amphotericin B (AmBisome) - 2 mg/kg body weight
Trial: 11850268
Drug: Amphotericin B
RxNorm normalized name: Amphotericin B
DrugBank: Amphotericin B (DB00681)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amphotericin B deoxycholate (AMB-DOC) - 0.6 mg/kg body weight
Trial: 1533259
Drug: Enalapril (20-40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enalapril (20-40 mg/day)
Trial: 8557971
Drug: Nifedipine-GITS (30-60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nifedipine-GITS (30-60 mg/day)
Trial: 8557971
Drug: Aspirin (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin (100 mg/day for 2 weeks)
Trial: 8557971
Drug: Indomethacin (75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indomethacin (75 mg/day for 1 week)
Trial: 1956698
Drug: Hybrid synthetic
RxNorm normalized name: Synthetic camphor
DrugBank: Synthetic camphor (DB14156)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hybrid synthetic polypeptide vaccine containing epitopes from four proteins of Plasmodium falciparum
Trial: 6452794
Drug: Desipramine 75
RxNorm normalized name: desipramine 75 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Desipramine 75 mg b.i.d.
Trial: 6452794
Drug: Zimelidine 100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zimelidine 100 mg b.i.d.
Trial: 6215831
Drug: Both treatments
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both treatments (Zimelidine and Desipramine)
Trial: 26938214
Drug: Oral flucloxacillin
RxNorm normalized name: cloxacillin Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral flucloxacillin
Trial: 26938214
Drug: Oral and
RxNorm normalized name: Tridate, oral and rectal kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral and topical placebos
Trial: 16575724
Drug: Doxycycline (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doxycycline (200 mg/day) for 3 weeks
Trial: 8657524
Drug: Breakfast with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Breakfast with 25% of daily phenylalanine allowance and lunch with 30%
Trial: 8657524
Drug: Breakfast with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Breakfast with 50% of daily phenylalanine allowance and lunch with 10%
Trial: 8657524
Drug: Breakfast with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Breakfast with 75% of daily phenylalanine allowance and lunch with 10%
Trial: 1632391
Drug: Lovastatin, 40
RxNorm normalized name: Lovastatin, 40 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lovastatin, 40 mg twice daily for 7 to 10 days before PTCA and continued for 6 months.
Trial: 6837492
Drug: Zinc supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zinc supplementation (20 mg zinc added to vitamin and mineral supplements)
Trial: 31375452
Drug: Nontargeted therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nontargeted therapy
Trial: 23417236
Drug: 2 ×
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 × 4 mL hylastan
Trial: 23417236
Drug: 1 ×
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 × 4 mL hylastan
Trial: 23417236
Drug: Steroid (IA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Steroid (IA methylprednisolone acetate 40 mg)
Trial: 23417236
Drug: All treatments
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All treatments (2 × 4 mL hylastan, 1 × 4 mL hylastan, steroid)
Trial: 22331761
Drug: Test: 0.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Test: 0.2 mg misoprostol tablet
Trial: 22331761
Drug: Reference: branded
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reference: branded misoprostol tablet
Trial: 20655543
Drug: High-DHA algal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-DHA algal oil (∼200 mg/d of DHA)
Trial: 2406859
Drug: Bismuth subsalicylate
RxNorm normalized name: Bismuth Subsalicylate
DrugBank: Bismuth subsalicylate (DB01294)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Bismuth subsalicylate (300 mg every 30 minutes, total of 2.4 g in eight doses)
Trial: 31513088
Drug: Bushen Tiaogan
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bushen Tiaogan formula (BSTG) plus traditional Chinese medicine-based psychotherapy (TBP)
Trial: 31513088
Drug: Placebo plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo plus traditional Chinese medicine-based psychotherapy (TBP)
Trial: 28762354
Drug: Enamel microabrasion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enamel microabrasion (EM) followed by in‐office bleaching with 44% carbamide peroxide gel
Trial: 23463625
Drug: Dose-modified capecitabine/irinotecan
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dose-modified capecitabine/irinotecan (mCapIri) plus bevacizumab
Trial: 8924193
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg citalopram infusion
Trial: 3891362
Drug: Dihydroxybusulfan (B)
RxNorm normalized name: DIHYDROXYBUSULFAN
DrugBank: Treosulfan (DB11678)
FDA approved: no
EMA approved: yes
PMDA approved: no
Description: Dihydroxybusulfan (B) 600 mg/m2 p.o. for 4-6 weeks q 12 weeks